Drug Panel 9A, Urine - Screen with Reflex to Confirmation/Quantitation
Ordering Recommendation
Enzyme Immunoassay/Gas Chromatography-Flame Ionization Detection/Gas Chromatography-Mass Spectrometry/Liquid Chromatography-Tandem Mass Spectrometry
1-4 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Random urine.  
Specimen Preparation
Transfer 8 mL urine with no additives or preservatives in ARUP Standard Transport Tubes. (Min: 4 mL)  
Storage/Transport Temperature
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years  
Reference Interval
Effective August 20, 2012
Drugs Covered and Cutoff Concentrations
Drugs/Drug Classes Screen
Marijuana 20 ng/mL
Cocaine 150 ng/mL
Opiates 300 ng/mL
Oxycodone 100 ng/mL
Phencyclidine 25 ng/mL
Amphetamines 300 ng/mL
MDMA (Ecstasy) 500 ng/mL
Barbiturates 200 ng/mL
Benzodiazepines 200 ng/mL
Methadone 150 ng/mL
Propoxyphene 300 ng/mL
Alcohol 40 mg/dL
Interpretive Data
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS, GC/FID, and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

For medical purposes only; not valid for forensic use.

Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results. The following opioids are not detected in this test: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to for test information.  
If the specimen screens positive, then Confirmation/Quantitation by GC/MS, GC/FID, and/or LC-MS/MS will be added to confirm result. Additional charges apply.

To order testing for individual opioids, refer to Fentanyl and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 0092570), Buprenorphine and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2010092), Meperidine and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 2002760), Tramadol and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).

CPT Code(s)
80301; if positive, add appropriate CPT code(s): 80320; 80326; 80345; 80347; 80349; 80353; 80358; 80364; 80367; 83992; (Alt code: G0431; if positive, add appropriate CPT code(s): G6042; G6031; G6040;G6043; G6044; G6053; G6056; 83992; 82491 x2)
Component Test Code*Component Chart NameLOINC
0090386Creatinine, Urine2161-8
0090406CDASU 9A Comments48767-8
0092191Amphetamines, Urine19348-2
0092192Cocaine, Urine19363-1
0092193Opiates, Urine19300-3
0092194Phencyclidine, Urine19661-8
0092195Marijuana, Urine19292-2
0092196Barbiturates, Urine19276-5
0092197Benzodiazepines, Urine19284-9
0092198Propoxyphene, Urine19432-4
0092199Methadone, Urine19553-7
0092400Alcohol, Urine46983-3
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Alcohol, Urine
  • Amphetamines, Urine
  • Barbiturates, Urine;
  • Benzodiazepines, Urine
  • Cocaine, Urine
  • Creatinine, Urine
  • Marijuana, Urine
  • Methadone, Urine
  • Opiates, Urine
  • Pain Management
  • Phencyclidine, Urine
  • Propoxyphene, Urine